Cargando…
SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a progressive chronic disease associated with severe microvascular and macrovascular complications. Our aim is to assess the real world effectiveness of SGT" inhibitors in achieving metabolic therapeutic goals. METHODS: A retrospective, observation...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493113/ https://www.ncbi.nlm.nih.gov/pubmed/28680862 http://dx.doi.org/10.1186/s40200-017-0308-4 |